Glycogen is how animals, including people, store glucose (the simple sugar in your blood) for later. The body packs thousands of glucose units into compact particles, mainly in the liver and muscles. It works like a quick-access savings account: it fills after meals and gets drawn down between them or during exercise. Where the glycogen sits decides who can spend it, since stores in the liver serve the whole body while stores in a muscle serve only that muscle.1PubMed Central. The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise And because every step depends on one specific enzyme, a single faulty gene can break the system, showing up as low blood sugar, an enlarged liver, or muscles that cramp during effort.
How the Body Builds and Breaks Down Glycogen
Every new glycogen particle begins on a protein called glycogenin, which attaches sugar units to itself to form a short starter chain.2PubMed. Initiation of glycogen synthesis. Control of glycogenin by glycogen phosphorylase It can build a starter of about 12 to 13 glucose units, working alone or in pairs.3PubMed Central. Mechanisms of monomeric and dimeric glycogenin autoglucosylation Once the starter is long enough, glycogen synthase, the building enzyme, takes over and lengthens the chain.2PubMed. Initiation of glycogen synthesis. Control of glycogenin by glycogen phosphorylase It can only add glucose end to end, so what it makes are straight chains.
Straight chains alone would be a poor storage form, so a branching enzyme cuts off a piece of a growing chain and reattaches it to the side, creating a branch point.4Fundamentals of Biochemistry. Glycogen Metabolism: Pathways, Control, and Genetic Regulation5PubMed Central. The unique branching patterns of Deinococcus glycogen branching enzymes are determined by their N-terminal domains Glycogen becomes a tree-like particle with many loose ends. Packing glucose into one big molecule also avoids drawing water into cells the way the same amount of loose sugar would. In the liver and heart, single particles can clump into larger rosette-shaped clusters.6PubMed. Normal and abnormal glycogen structure – A review
Breaking glycogen down is a separate job. Glycogen phosphorylase, the breakdown enzyme, clips glucose units off the ends of the chains one at a time. Each unit comes off already carrying a phosphate tag, so it is trapped in the cell and ready for use without spending extra energy to activate it. But the enzyme stalls when it gets within four units of a branch point.7PubMed. Essential dextrin structure as donor substrate for 4-α-glucanotransferase in glycogen debranching enzyme A debranching enzyme with two separate working sites steps in.8PubMed. Effects of oligosaccharide binding on glycogen debranching enzyme activity and conformation9PubMed. Fluorogenic substrates of glycogen debranching enzyme for assaying debranching activity One site moves a three-unit stub to another chain and the other cuts away the single glucose left at the branch.9PubMed. Fluorogenic substrates of glycogen debranching enzyme for assaying debranching activity7PubMed. Essential dextrin structure as donor substrate for 4-α-glucanotransferase in glycogen debranching enzyme With the branch cleared, the breakdown enzyme can keep working into the inner layers of the particle.7PubMed. Essential dextrin structure as donor substrate for 4-α-glucanotransferase in glycogen debranching enzyme
Separate enzymes let the body turn one route on while turning the other off; if both ran at once, the cell would burn energy in a pointless loop. That makes these two enzymes the main control points.
Cells have a second, slower route too. They can wrap glycogen up and send it to the lysosome, the cell’s recycling compartment.10PubMed Central. Lysosomal glucose sensing and glycophagy in metabolism There an enzyme called acid alpha-glucosidase breaks both straight links and branch points to free glucose.10PubMed Central. Lysosomal glucose sensing and glycophagy in metabolism The main route in the cytoplasm (the cell’s fluid interior) is the fast, hormone-controlled one that supplies glucose within minutes. The lysosome route is not driven in the same way by the insulin and glucagon switches, so it works more like background housekeeping. Because the two routes use different enzymes, a fault in one does not automatically disable the other, and the resulting diseases look different.
What Switches Glycogen Storage On and Off
Enzymes are often switched by attaching or removing small phosphate tags. The building enzyme can carry tags on nine different spots, and more tags make it work less.11PubMed. Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance So insulin promotes storage by getting those tags removed.12Endocrine Reviews. The Role of Protein Phosphatase-1 in Insulin Action It does this by damping the enzymes that add tags, cutting the activity of one of them by about half in muscle and fat.13PubMed. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue It also activates a tag-removing enzyme, which also helps shut off glycogen breakdown.12Endocrine Reviews. The Role of Protein Phosphatase-1 in Insulin Action
Tags can be added or removed in seconds without making new enzyme. The same tag can turn the building enzyme off and the breakdown enzyme on, so one hormone signal can flip the whole system in one direction.
A sugar signal inside the cell gives a second push. When glucose enters a cell it is converted to glucose-6-phosphate. This molecule binds the building enzyme directly and boosts its activity and its grip on raw material.14PubMed. Allosteric regulation of glycogen synthase controls glycogen synthesis in muscle11PubMed. Regulation of muscle glycogen synthase phosphorylation and kinetic properties by insulin, exercise, adrenaline and role in insulin resistance It does so by making the enzyme’s parts rotate outward, opening access to its working site.15PubMed Central. Molecular basis for the regulation of human glycogen synthase by phosphorylation and glucose-6-phosphate Plenty of incoming sugar can therefore drive storage even before hormones fully act.
Hormones tell the cell about the whole body, such as whether you have just eaten or are fasting. Glucose-6-phosphate tells the cell about its own local supply, so storage matches what is actually arriving.
Between meals the pancreas releases glucagon, which signals the liver to release glucose. In rats, glucagon cut the liver’s activity of a tag-removing enzyme on the breakdown pathway by about 20% within 5 minutes.16PubMed. Acute regulation of hepatic protein phosphatases by glucagon, insulin, and glucose. Insulin plus glucose, by contrast, raised these tag-removing activities by about 35%.16PubMed. Acute regulation of hepatic protein phosphatases by glucagon, insulin, and glucose. Adrenaline during stress or a sudden sprint also triggers rapid breakdown.
Why Liver and Muscle Glycogen Do Different Jobs
A main job of glycogen is keeping blood glucose steady, but only liver glycogen feeds glucose into the blood.1PubMed Central. The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise Muscles lack glucose-6-phosphatase, the enzyme that removes the last tag so glucose can exit the cell.1PubMed Central. The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise Muscle glycogen is a local fuel for exercise, not a reserve for fasting.1PubMed Central. The Role of Skeletal Muscle Glycogen Breakdown for Regulation of Insulin Sensitivity by Exercise17Nutrition and Physical Fitness. Carbohydrate Metabolism So liver glycogen is drawn down between meals and overnight, while muscle glycogen drops mainly during activity.17Nutrition and Physical Fitness. Carbohydrate Metabolism
When either organ breaks down glycogen, the glucose comes off as glucose-6-phosphate, still tagged. In the liver, glucose-6-phosphatase strips the tag, and untagged glucose can leave the cell and enter the blood. In muscle, with no such enzyme, the tagged glucose goes straight into the muscle’s own energy-producing steps.
Storage is split by organ, and muscle stores are private. That is why a low-blood-sugar spell can happen even in someone with well-stocked muscles. In a long run, the legs burn their own glycogen and cannot borrow from idle arm muscles. When liver glycogen runs low, the body leans more on making new glucose and burning fat.
Control fits each organ’s job. The liver responds strongly to glucagon because its task is serving the whole body, while muscle responds mainly to insulin, adrenaline and its own contractions. The liver can also turn extra carbohydrate into fat instead of glycogen, guided by a glucose-sensing gene switch. Mice without it store more liver glycogen and less fat.18PubMed. ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome
When Genes Break the System, Glycogen Storage Diseases
The name glycogen storage disease (GSD) can mislead. In many types the problem is not too little glycogen but glycogen that cannot be used. Sometimes the glycogen is normal in structure but cannot be used, as when a breakdown enzyme is missing. In others the glycogen itself is abnormal. Which step failed matters more than how much glycogen is present, and the broken step predicts the symptoms.
In glycogen storage disease type Ia, the gene for the liver’s glucose-releasing enzyme, glucose-6-phosphatase, is faulty.19PubMed Central. Mutations in the Glucose-6-Phosphatase-α (G6PC) Gene that Cause Type Ia Glycogen Storage Disease Blood sugar falls after even a short fast.19PubMed Central. Mutations in the Glucose-6-Phosphatase-α (G6PC) Gene that Cause Type Ia Glycogen Storage Disease Normally this enzyme performs the last step of both glycogen breakdown and new glucose production, so in type Ia both routes fail at once. The trapped sugar backs up into glycogen, which builds up and enlarges the liver and kidneys.19PubMed Central. Mutations in the Glucose-6-Phosphatase-α (G6PC) Gene that Cause Type Ia Glycogen Storage Disease The backlog also raises blood fats, cholesterol, uric acid and lactic acid.19PubMed Central. Mutations in the Glucose-6-Phosphatase-α (G6PC) Gene that Cause Type Ia Glycogen Storage Disease
McArdle disease, also called type V, comes from faults in the PYGM gene for the muscle breakdown enzyme.20PubMed. Cell models for McArdle disease and aminoglycoside-induced read-through of a premature termination codon21PubMed. Genes and exercise intolerance: insights from McArdle disease Muscles cannot use their own glycogen, and the disease affects muscle only.22PubMed Central. A novel compound heterozygous mutation in PYGM gene associated with McArdle’s disease People tire quickly and get cramps or pain early in intense exercise. It is recessive, so a child must inherit a faulty copy from each parent.22PubMed Central. A novel compound heterozygous mutation in PYGM gene associated with McArdle’s disease
Lafora disease is a severe epilepsy that usually begins in the teens and is typically fatal within about 10 years.23PubMed Central. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo Poorly branched, insoluble glycogen-like clumps called Lafora bodies form in nerve, muscle and liver cells, and the abnormal deposits damage the brain.23PubMed Central. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo About half of cases come from faults in the gene for laforin, an enzyme that removes the small amount of phosphate normally in glycogen.24PubMed Central. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease23PubMed Central. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo Without it phosphate builds up, about fourfold in mouse muscle, and glycogen becomes poorly branched and clumps.24PubMed Central. Abnormal metabolism of glycogen phosphate as a cause for Lafora disease23PubMed Central. Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo Laforin also works with a partner, malin, to rein in the building enzyme on chains growing too long.25PubMed Central. Pathogenesis of Lafora Disease: Transition of Soluble Glycogen to Insoluble Polyglucosan
How Exercise Changes Glycogen Stores
A hard workout that drains muscle glycogen switches on an energy sensor called AMPK that stays active into recovery.26PubMed Central. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle The muscle becomes more sensitive to insulin and pulls in more glucose.26PubMed Central. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle AMPK also shifts the muscle toward burning fat, saving glucose for storage.26PubMed Central. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle27PubMed Central. Interactive Roles for AMPK and Glycogen from Cellular Energy Sensing to Exercise Metabolism The building enzyme stays on even after stores are back to normal.26PubMed Central. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle So muscle can store more glycogen than before, an overshoot known as supercompensation.26PubMed Central. Exercise-induced molecular mechanisms promoting glycogen supercompensation in human skeletal muscle
Eating carbohydrate in the hours after hard training helps refill stores while muscles are primed. Carb-loading before endurance events relies on the same refill-and-overshoot effect. Supercompensation needs both the drain and enough carbohydrate to refill, and it is a temporary rise, not a permanent new level.
The same priming helps blood sugar control. Muscles emptied of glycogen soak up blood glucose to refill, which is one reason regular activity improves insulin sensitivity.
Glycogen in the Brain, the Heart, and Diabetes Treatment
In the brain, glycogen sits mainly in support cells called astrocytes rather than nerve cells. In animals, blocking glycogen breakdown impaired memory formation.28PubMed. The metabolic trinity, glucose-glycogen-lactate, links astrocytes and neurons in brain energetics, signaling, memory, and gene expression Whether astrocytes feed nerve cells lactate from this glycogen, as some propose, is not firmly proven.29PubMed Central. Astrocyte glycogen and lactate: new insights into learning and memory mechanisms28PubMed. The metabolic trinity, glucose-glycogen-lactate, links astrocytes and neurons in brain energetics, signaling, memory, and gene expression The stores are tiny compared with those in liver and muscle, and are thought to act as a brief buffer during intense nerve activity or when glucose is scarce.
Heart glycogen helps briefly, then can hurt. In rat hearts, high glycogen protected against short loss of blood flow.30PubMed. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved In longer loss of blood flow, glycogen ran out and the acid it produced worsened damage.30PubMed. Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved These brain and heart results come mainly from animal studies.
In type 2 diabetes the liver releases too much glucose, so drugs that block the breakdown enzyme lower blood sugar in diabetic animals.31PubMed. Glycogen phosphorylase inhibitors for treatment of type 2 diabetes mellitus In diabetic mice one such drug cut blood sugar within 3 hours without causing low blood sugar.32PubMed. Discovery of a human liver glycogen phosphorylase inhibitor that lowers blood glucose in vivo In rats it did not appear to hamper muscle performance.33PubMed. Glycogen phosphorylase inhibition in type 2 diabetes therapy: a systematic evaluation of metabolic and functional effects in rat skeletal muscle This is a tricky target, because related forms of the enzyme work in muscle and a drug must spare muscle fuel. Stopping liver release too hard could risk low blood sugar, so developers aim at the liver form specifically. These drugs are still experimental and not approved treatments.

